Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.72M Buy
36,729
+880
+2% +$103K 2.44% 15
2026
Q1
$4.31M Sell
35,849
-1,324
-4% -$153K 2.59% 13
2025
Q4
$3.91M Sell
37,173
-2,753
-7% -$258K 2.09% 15
2025
Q3
$3.35M Sell
39,926
-1,173
-3% -$96.6K 1.77% 16
2025
Q2
$3.25M Sell
41,099
-2,446
-6% -$194K 1.79% 18
2025
Q1
$3.91M Sell
43,545
-2,019
-4% -$189K 2.21% 16
2024
Q4
$4.53M Sell
45,564
-2,855
-6% -$294K 2.25% 14
2024
Q3
$5.5M Sell
48,419
-1,833
-4% -$218K 2.7% 13
2024
Q2
$6.22M Sell
50,252
-7,468
-13% -$962K 2.8% 13
2024
Q1
$7.56M Buy
57,720
+16,749
+41% +$2.06M 2.38% 16
2023
Q4
$4.47M Buy
40,971
+40,595
+10,797% +$4.21M 2.21% 15
2023
Q3
$38.7K Hold
376
0.02% 71
2023
Q2
$43.4K Hold
376
0.02% 89
2023
Q1
$39.9K Buy
+376
New +$40.6K 0.03% 83

Other funds holding MRK

Brown Shipley & Co's MRK Position: Q2 2026 in Review

Brown Shipley & Co increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $103K and bringing the position to 36,729 shares worth $4.72M. The position accounts for 2.44% of the portfolio, ranked #15.

Brown Shipley & Co first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.56M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Brown Shipley & Co held 36,729 shares of Merck worth $4.72M as of Q2 2026.
  • Brown Shipley & Co bought 880 Merck shares in Q2 2026, an estimated $103K.
  • Merck made up 2.44% of Brown Shipley & Co's portfolio in Q2 2026, its #15 holding.
  • Brown Shipley & Co first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • Brown Shipley & Co's Merck position peaked at $7.56M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Brown Shipley & Co's 13F filing for Q2 2026, filed 14 Jul 2026.